Although the malonyl-CoA sensitivity of peroxisomal carnitine octanoyltransferase (COT) is reportedly lost on solubilization, we show that malonyl-CoA does inhibit the purified enzyme. Assay conditions such as buffer composition, pH, acyl-CoA substrate and the presence or absence of BSA can affect the observed inhibition. When assayed in the absence of BSA, COT shows simple competitive inhibition by malonyl-CoA. The K, value for inhibition of purified COT is high (106,UM) compared with physiological concentrations (1-6 M) and other short-chain acyl-CoA esters inhibit COT to the same degree. However, when COT is assayed in intact peroxisomes, the K1 for malonyl-CoA is almost 20-fold lower than found with the purified enzyme, whereas inhibition by other short-chain acyl-CoA esters does not change significantly. Several features of the inhibition of peroxisomal COT, including the specificity of malonyl-CoA over other short-chain acyl-CoA esters, resemble those of carnitine palnitoyltransferase (CPT)-I, suggesting that the regulation of COT and CPT-I in parallel may be necessary for the control of cellular fatty acid metabolism.
INTRODUCTION
The carnitine acyltransferase enzymes catalyse the reversible transfer of acyl groups from CoA to L-carnitine. The inhibition of the overt carnitine palmitoyltransferase (EC 2.3.1.21; CPT-I) on the mitochondrial outer membrane by malonyl-CoA is important in the regulation of the ,8-oxidation of long-chain fatty acids and ketone-body synthesis [1, 2] . Other malonyl-CoAsensitive carnitine acyltransferase activities have been found in peroxisomes [3] and microsomes [4] . Although the proposed role of peroxisomal carnitine octanoyltransferase (COT) in shuttling chain-shortened acyl groups from peroxisomes to mitochondria remains unconfirmed, the malonyl-CoA sensitivity suggests that COT is also important in the overall pattern of fatty acid metabolism in the cell [3] . The malonyl-CoA sensitivity of peroxisomal COT, like that ofmitochondrial CPT-I, is reportedly lost on solubilization of the enzyme [3, 5, 6] .
We have now examined in detail the inhibition of COT by malonyl-CoA and related compounds and have compared the characteristics of the inhibition of the purified enzyme with the inhibition of the enzyme in intact peroxisomes.
EXPERIMENTAL
Essentially fatty-acid-free BSA, palmitoyl-CoA, decanoylCoA, malonyl-CoA, glutaryl-CoA, 3-hydroxy-3-methylglutarylCoA, methylmalonyl-CoA and L-carnitine were all obtained from Sigma. Aldrithiol (4,4'-dithiobispyridine) was obtained from Aldrich. COT was purified from bovine liver as described in [7] . Rat liver peroxisomes were prepared by centrifugation through Nycodenz [3] . COT was assayed in the forward direction by measuring the released CoA by its reaction with aldrithiol at 324 nm [3] . Km values were determined either by fitting the initialrate data to a rectangular hyperbola or by fitting the data from the entire progress curve of the reaction to the integrated form of the Michaelis-Menten equation. Kinetic and inhibition constants were determined by linear or non-linear regression analysis as appropriate.
RESULTS

Assay conditions
As is well known for CPT, the activity of COT is sensitive to changes in assay conditions. The observed reaction velocity and sensitivity to inhibition are strongly influenced by the particular assay conditions employed. Since there is no universally used ' standard assay', comparison of the data obtained from different laboratories using different assay systems is difficult. BSA is commonly included in the assay of COT and CPT in order to minimize the problems associated with micellar formation and the detergent properties of fatty acyl-CoA esters [8, 9] . However, the inclusion of BSA in the assay medium itself causes complications in the interpretation of results, owing to the binding of fatty acyl-CoAs to BSA and the resultant change in free substrate concentration [10, 11] . [12, 13] . Although the control rate for the COT reaction is not changed between pH 7.4 and 6.8, a 20-30 % increase in inhibition by malonyl-CoA is observed when the pH is decreased from 7.4 to 6.8 (see also below).
Kinetics of inhibition of purified COT
In a simple assay system (without BSA), namely 20 mMpotassium phosphate buffer, pH 7.4, 125 ,uM-aldrithiol and saturating L-carnitine, the concentrations of palmitoyl-CoA and malonyl-CoA were varied (Fig. 2) I several-fold [12, 131 , has the same effect on the inhibition of purified COT. 
Kinetics of COT assayed in peroxisomes
Because the 4, value for malonyl-CoA inhibition is so much higher than the physiological range of malonyl-CoA concentrations (1-6 /M) [16] and than the IC50 observed for COT in isolated peroxisomes [3] , we also examined the kinetics of the enzyme in peroxisomes. (Tables 1 and 2 ). Changes in assay conditions are particularly important in the kinetics of the inhibition of acyltransferases by malonyl-CoA, since IC5,, values are critically dependent on the substrate concentration used. The data presented demonstrate not only that purified COT is inhibited competitively by malonyl-CoA, but also that, when the assay conditions are changed, the observed properties of the sensitivity of COT to malonyl-CoA mimic those observed for CPT-I. A direct plot of the inhibition of COT by malonyl-CoA in the presence of BSA (Fig. 1) is sigmoidal, and malonylCoA increases this sigmoidicity, an effect that has been observed -for CPT-I in intact mitochondria [17] [12] .
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A pH-dependent increase in sensitivity is also observed for purified COT (Table 2 ) and may be due to the presence of a histidine residue in the active site. An active-site histidine which has been identified in carnitine acetyltransferase [18] , and has been proposed for CPT-I [13, 15] , would titrate over the pH range 6.8-7.4. The effect of BSA and pH on the inhibition kinetics of COT suggests that all of these properties of malonyl-CoA inhibition of COT can be explained by features of the 62 500-Da peptide of the purified preparation.
Malonyl-CoA inhibition of purified COT is competitive with respect to pahnitoyl-CoA, and the degree of inhibition with malonyl-CoA is similar to that seen with other short-chain acylCoA esters (Table 3) . Thus the inhibition is likely to be due to the common acyl-CoA moiety of those compounds, interacting with COT at the substrate-binding site. The K, value for the inhibition of purified COT by malonyl-CoA is rather high in comparison with cellular concentrations of 1-6gM [16] . Thus this interaction is not likely to be physiologically significant.
Although COT has been called a 'soluble' enzyme [5] , incomplete liberation of the enzyme activity is obtained by sonication of peroxisomes [3] . We therefore thought that the enzyme might be membrane-bound in vivo, which might affect its kinetic behaviour, so we compared the properties of the enzyme in isolated peroxisomes with those of the purified enzyme. Both forms of the enzyme show similar Km values for fatty acyl-CoA substrates and show little inhibition by several short-chain acylCoA esters (Table 3) . However, the K1 value for inhibition by malonyl-CoA in peroxisomes was dramatically lower, at 6.4 #M (almost 20-fold lower than for the isolated enzyme) ( Table 3) .
The specificity of the inhibition by malonyl-CoA displays a great discrimination by the membrane-bound enzyme between malonyl-CoA and other short-chain acyl-CoA esters. Mitochondrial CPT-I is also specifically inhibited by malonyl-CoA, with other short-chain acyl-CoA esters inhibiting to a much lesser extent [19] . There is some evidence that CPT-I malonylCoA sensitivity is conferred by a regulatory subunit bearing a specific malonyl-CoA-binding site [20] [21] [22] . A similar model could account for the malonyl-CoA inhibition of peroxisomal COT. A regulatory subunit with a malonyl-CoA-binding site may be lost on solubilization of the enzyme, with a consequent decrease in sensitivity to inhibition. Alternatively, the catalytic polypeptide could contain a separate binding site for malonyl-CoA, but on solubilization of the enzyme a conformation change occurs that results in a lowered affinity for malonyl-CoA at this regulatory site. A separate binding site for malonyl-CoA (either on the catalytic polypeptide or on a regulatory subunit) could explain why Km values for both substrates do not change from peroxisomes to the purified enzyme (Table 3) ; the only kinetic parameter to change in the K. for malonyl-CoA. Such a site could also explain the efficacy of malonyl-CoA over other short-charn acylCoA esters in inhibiting COT in peroxisomes. It should be noted that the pattern of competitive inhibition observed with malonylCoA does not preclude the existence of a separate binding site for malonyl-CoA, even in the purified enzyme. Competitive inhibition merely indicates that the binding of malonyl-CoA interferes with substrate binding.
Lastly, since the features of the inhibition of COT by malonylCoA resemble those of CPT-I, peroxisomal COT could be regulated in tandem with CPT-I for effective control of cellular fatty acid metabolism. Thus the role of COT in peroxisomes and regulation of its activity must be significant in the overall pattern of lipid metabolism in the cell.
